Medical cannabis: aligning use to evidence-based medicine approach

被引:26
|
作者
Schleider, Lihi Bar-Lev
Abuhasira, Ran
Novack, Victor [1 ]
机构
[1] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Cannabis Clin Res Inst, Beer Sheva, Israel
关键词
MULTIPLE-SCLEROSIS; OPEN-LABEL; PARKINSON DISEASE; NEUROPATHIC PAIN; CONTROLLED-TRIAL; CROHNS-DISEASE; ADD-ON; EFFICACY; SAFETY; DELTA(9)-TETRAHYDROCANNABINOL;
D O I
10.1111/bcp.13657
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.
引用
收藏
页码:2458 / 2462
页数:5
相关论文
共 50 条